nach oben

Journal of Neurology

Erschienen in:

28.01.2019 | Review

Pre-treatment cerebral microbleeds and intracranial hemorrhage in patients with ischemic stroke receiving endovascular therapy: a systematic review and meta-analysis

verfasst von: Xiumei Wu, Jiangzhi Yan, Huirong Ye, Jianting Qiu, Jian Wang, Yujie Wang

Erschienen in: Journal of Neurology | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Background and purpose

Predicting the risk of intracranial hemorrhage (ICH) is an important aspect for improving the efficacy and safety of endovascular therapy (EVT). We intended to perform a systematic review and meta-analysis to show whether pre-treatment cerebral microbleeds (CMBs) were associated with an increased incidence of ICH in patients with ischemic stroke receiving EVT.

Methods

We searched PubMed, EMBASE, Web of Science and Cochrane Library from their dates of inception to December 18, 2018, and also manually searched reference lists of relevant articles. Cumulative prevalence of CMBs and ICH was calculated. Relative risk and 95% confidence interval (CI) were calculated for the incidence of ICH in patients with CMBs versus those without after EVT.

Results

Four studies involving 598 patients were included. The pooled prevalence of CMBs was 18% (95% CI 15–21%) and the pooled prevalence of ≥ 5 CMBs was 1% (95% CI 0–2%). The pooled incidence of ICH was 29% (95% CI 8–49%) in all patients, 25% (95% CI 5–45%) in those with CMBs and 29% (95% CI 8–50%) in those without CMBs. The pooled relative risk of ICH was 0.90 (95% CI 0.65–1.25, P = 0.528; I² = 0%, P = 0.949) in patients with CMBs versus those without CMBs.

Conclusions

There is no evidence that pre-treatment CMBs were associated with an increased incidence of ICH in patients with ischemic stroke receiving EVT.

Nur mit Berechtigung zugänglich

Sacks D, Baxter B, Campbell BCV, Carpenter JS, Cognard C, Dippel D, Eesa M, Fischer U, Hausegger K, Hirsch JA, Hussain MS, Jansen O, Jayaraman MV, Khalessi AA, Kluck BW, Lavine S, Meyers PM, Ramee S, Rufenacht DA, Schirmer CM, Vorwerk D (2018) Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. AJNR Am J Neuroradiol 39(6):E61–E76. https://doi.org/10.3174/ajnr.A5638 CrossRefPubMedPubMedCentral

Hong KS, Ko SB, Yu KH, Jung C, Park SQ, Kim BM, Chang CH, Bae HJ, Heo JH, Oh CW, Lee BC, Kim BT, Kim BS, Chung CS, Yoon BW, Rha JH (2016) Update of the Korean clinical practice guidelines for endovascular recanalization therapy in patients with acute ischemic stroke. J Stroke 18(1):102–113. https://doi.org/10.5853/jos.2015.01655 CrossRefPubMedPubMedCentral

Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, Clark W, Budzik R, Zaidat OO (2012) Solitaire flow restoration device versus the merci retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 380(9849):1241–1249. https://doi.org/10.1016/s0140-6736(12)61384-1 CrossRefPubMed

Phan K, Dmytriw AA, Maingard J, Asadi H, Griessenauer CJ, Ng W, Kewagamang K, Mobbs RJ, Moore JM, Ogilvy CS, Thomas AJ (2017) Endovascular thrombectomy alone versus combined with intravenous thrombolysis. World Neurosurg 108:850–858.e852. https://doi.org/10.1016/j.wneu.2017.08.040 CrossRefPubMed

Leng X, Fang H, Leung TW, Mao C, Miao Z, Liu L, Wong KS, Liebeskind DS (2016) Impact of collaterals on the efficacy and safety of endovascular treatment in acute ischaemic stroke: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 87(5):537–544. https://doi.org/10.1136/jnnp-2015-310965 CrossRefPubMed

Senior K (2002) Microbleeds may predict cerebral bleeding after stroke. Lancet 359(9308):769. https://doi.org/10.1016/s0140-6736(02)07911-4 CrossRefPubMed

Charidimou A, Krishnan A, Werring DJ, Rolf Jager H (2013) Cerebral microbleeds: a guide to detection and clinical relevance in different disease settings. Neuroradiology 55(6):655–674. https://doi.org/10.1007/s00234-013-1175-4 CrossRefPubMed

Charidimou A, Kakar P, Fox Z, Werring DJ (2013) Cerebral microbleeds and recurrent stroke risk: systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts. Stroke 44(4):995–1001. https://doi.org/10.1161/strokeaha.111.000038 CrossRefPubMed

Qiu J, Ye H, Wang J, Yan J, Wang J, Wang Y (2018) Antiplatelet therapy, cerebral microbleeds, and intracerebral hemorrhage: a meta-analysis. Stroke 49(7):1751–1754. https://doi.org/10.1161/strokeaha.118.021789 CrossRefPubMed

10.

Yan J, Qiu J, Wu X, Ge Y, Wang J, Wang Y (2018) Pretreatment cerebral microbleeds and symptomatic intracerebral hemorrhage post-thrombolysis: a systematic review and meta-analysis. J Neurol. https://doi.org/10.1007/s00415-018-9156-5 CrossRefPubMed

11.

Kidwell CS, Saver JL, Villablanca JP, Duckwiler G, Fredieu A, Gough K, Leary MC, Starkman S, Gobin YP, Jahan R, Vespa P, Liebeskind DS, Alger JR, Vinuela F (2002) Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke 33(1):95–98CrossRefPubMed

12.

Soo YO, Siu DY, Abrigo J, Yu S, Ng N, Ahuja AT, Wong LK, Leung TW (2012) Risk of intracerebral hemorrhage in patients with cerebral microbleeds undergoing endovascular intervention. Stroke 43(6):1532–1536. https://doi.org/10.1161/strokeaha.111.626853 CrossRefPubMed

13.

Kim HS, Lee DH, Ryu CW, Lee JH, Choi CG, Kim SJ, Suh DC (2006) Multiple cerebral microbleeds in hyperacute ischemic stroke: impact on prevalence and severity of early hemorrhagic transformation after thrombolytic treatment. AJR Am J Roentgenol 186(5):1443–1449. https://doi.org/10.2214/ajr.04.1933 CrossRefPubMed

14.

Shi ZS, Duckwiler GR, Jahan R, Tateshima S, Gonzalez NR, Szeder V, Saver JL, Kim D, Ali LK, Starkman S, Vespa PM, Salamon N, Villablanca JP, Vinuela F, Feng L, Loh Y, Liebeskind DS (2016) Mechanical thrombectomy for acute ischemic stroke with cerebral microbleeds. J Neurointerventional Surg 8(6):563–567. https://doi.org/10.1136/neurintsurg-2015-011765 CrossRef

15.

Gratz PP, El-Koussy M, Hsieh K, von Arx S, Mono ML, Heldner MR, Fischer U, Mattle HP, Zubler C, Schroth G, Gralla J, Arnold M, Jung S (2014) Preexisting cerebral microbleeds on susceptibility-weighted magnetic resonance imaging and post-thrombolysis bleeding risk in 392 patients. Stroke 45(6):1684–1688. https://doi.org/10.1161/strokeaha.114.004796 CrossRefPubMed

16.

Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 350:g7647. https://doi.org/10.1136/bmj.g7647 CrossRefPubMed

17.

Haji S, Planchard R, Zubair A, Graff-Radford J, Rydberg C, Brown RD Jr, Flemming KD (2016) The clinical relevance of cerebral microbleeds in patients with cerebral ischemia and atrial fibrillation. J Neurol 263(2):238–244. https://doi.org/10.1007/s00415-015-7966-2 CrossRefPubMed

18.

Wilson D, Ambler G, Shakeshaft C, Brown MM, Charidimou A, Al-Shahi Salman R, Lip GYH, Cohen H, Banerjee G, Houlden H, White MJ, Yousry TA, Harkness K, Flossmann E, Smyth N, Shaw LJ, Warburton E, Muir KW, Jager HR, Werring DJ (2018) Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol 17(6):539–547. https://doi.org/10.1016/s1474-4422(18)30145-5 CrossRefPubMedPubMedCentral

19.

Hao Y, Zhang Z, Zhang H, Xu L, Ye Z, Dai Q, Liu X, Xu G (2017) Risk of intracranial hemorrhage after endovascular treatment for acute ischemic stroke: systematic review and meta-analysis. Interv Neurol 6(1–2):57–64. https://doi.org/10.1159/000454721 CrossRefPubMedPubMedCentral

20.

Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, Yan B, Dowling RJ, Parsons MW, Oxley TJ, Wu TY, Brooks M, Simpson MA, Miteff F, Levi CR, Krause M, Harrington TJ, Faulder KC, Steinfort BS, Priglinger M, Ang T, Scroop R, Barber PA, McGuinness B, Wijeratne T, Phan TG, Chong W, Chandra RV, Bladin CF, Badve M, Rice H, de Villiers L, Ma H, Desmond PM, Donnan GA, Davis SM (2015) Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 372(11):1009–1018. https://doi.org/10.1056/NEJMoa1414792 CrossRefPubMed

21.

Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, Roy D, Jovin TG, Willinsky RA, Sapkota BL, Dowlatshahi D, Frei DF, Kamal NR, Montanera WJ, Poppe AY, Ryckborst KJ, Silver FL, Shuaib A, Tampieri D, Williams D, Bang OY, Baxter BW, Burns PA, Choe H, Heo JH, Holmstedt CA, Jankowitz B, Kelly M, Linares G, Mandzia JL, Shankar J, Sohn SI, Swartz RH, Barber PA, Coutts SB, Smith EE, Morrish WF, Weill A, Subramaniam S, Mitha AP, Wong JH, Lowerison MW, Sajobi TT, Hill MD (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372(11):1019–1030. https://doi.org/10.1056/NEJMoa1414905 CrossRefPubMed

22.

Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, San Roman L, Serena J, Abilleira S, Ribo M, Millan M, Urra X, Cardona P, Lopez-Cancio E, Tomasello A, Castano C, Blasco J, Aja L, Dorado L, Quesada H, Rubiera M, Hernandez-Perez M, Goyal M, Demchuk AM, von Kummer R, Gallofre M, Davalos A (2015) Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 372(24):2296–2306. https://doi.org/10.1056/NEJMoa1503780 CrossRefPubMed

23.

Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, Albers GW, Cognard C, Cohen DJ, Hacke W, Jansen O, Jovin TG, Mattle HP, Nogueira RG, Siddiqui AH, Yavagal DR, Baxter BW, Devlin TG, Lopes DK, Reddy VK, du de Rochemont M, Singer R, Jahan OC R (2015) Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 372(24):2285–2295. https://doi.org/10.1056/NEJMoa1415061 CrossRefPubMed

24.

Fisher M, French S, Ji P, Kim RC (2010) Cerebral microbleeds in the elderly: a pathological analysis. Stroke 41(12):2782–2785. https://doi.org/10.1161/strokeaha.110.593657 CrossRefPubMedPubMedCentral

25.

Hopewell S, McDonald S, Clarke M, Egger M (2007) Grey literature in meta-analyses of randomized trials of health care interventions. Cochrane Database Syst Rev (2):Mr000010. https://doi.org/10.1002/14651858.MR000010.pub3

26.

Cheng AL, Batool S, McCreary CR, Lauzon ML, Frayne R, Goyal M, Smith EE (2013) Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds. Stroke 44(10):2782–2786. https://doi.org/10.1161/strokeaha.113.002267 CrossRefPubMed

Titel: Pre-treatment cerebral microbleeds and intracranial hemorrhage in patients with ischemic stroke receiving endovascular therapy: a systematic review and meta-analysis
verfasst von: Xiumei Wu
Jiangzhi Yan
Huirong Ye
Jianting Qiu
Jian Wang
Yujie Wang
Publikationsdatum: 28.01.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 5/2020
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-019-09210-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background and purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2020

Biomechanical response of the CNS is associated with frailty in NPH-suspected patients

Correction to: Minimally conscious state “plus”: diagnostic criteria and relation to functional recovery

ALS-derived fibroblasts exhibit reduced proliferation rate, cytoplasmic TDP-43 aggregation and a higher susceptibility to DNA damage

The 2019 novel cornoavirus pneumonia with onset of oculomotor nerve palsy: a case study

Cognitive and behavioral status in Japanese ALS patients: a multicenter study

Effective long-term treatment with incobotulinumtoxin (Xeomin®) without neutralizing antibody induction: a monocentric, cross-sectional study